We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Ypsomed is advancing its patch injector into a comprehensive solution by entering into a collaboration with SCHOTT and Lonza. In a joint effort, the three companies are developing a solution for wearable patch injectors for the subcutaneous ...
Ypsomed has entered into a collaboration with Schott and Lonza to be able to offer the YpsoDose patch injector platform, which is used for the subcutaneous self-administration of high volumes of pharmaceuticals, as a fully integrated solution.